Product
CoV2 preS dTM adjuvanted vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine and a Booster Dose of Pfizer-BioNTech or Moderna mRNA VaccineStatus: Active (not recruiting), Estimated PCD: 2022-07-15